PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Apr-2021 Sensient Announces Conference Call Businesswire
12-Apr-2021 Xilio Therapeutics Strengthens Management Team with R&D Leadership Appointments Businesswire
12-Apr-2021 AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System Businesswire
12-Apr-2021 Life sciences, business and research leaders ask Prime Minister Trudeau for a new approach to the sector, so Canadians can get back to those ‘everyday moments’ Businesswire
12-Apr-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Apr-2021 Corporate Reputations Improve During a Year of Crises according to The RepTrak Company Businesswire
12-Apr-2021 Global Active Pharmaceutical Ingredients (API) Market Trend Forecast and Growth Opportunity 2021-2027, by Synthesis, Manufacturing Process, Therapeutic Application, Drug Type and Region - ResearchAndMarkets.com Businesswire
12-Apr-2021 Yokogawa Selects C3 AI Suite to Enhance Enterprise AI Applications Businesswire
12-Apr-2021 HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity Businesswire
11-Apr-2021 BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021 Businesswire
09-Apr-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Franklin Wireless Corp. (FKWL) on Behalf of Investors Businesswire
09-Apr-2021 Precision BioSciences to Participate in the Truist Securities 2021 Life Sciences Virtual Series Businesswire
09-Apr-2021 Seagen and Genmab Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer Businesswire
09-Apr-2021  Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer Businesswire
09-Apr-2021 MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications. Businesswire
09-Apr-2021 Repertoire Immune Medicines to Present Data from Autologous T Cell Therapy -- PRIME IL-15 (RPTR-147) -- in Advanced or Metastatic Solid Tumor Cancers Businesswire
09-Apr-2021 Worldwide Allergic Conjunctivitis Industry to 2027 - by Countries, Disease Type, Pipeline Drugs and Company Analysis - ResearchAndMarkets.com Businesswire
09-Apr-2021 Global Genetic Testing Market Applications and Technologies Report 2021-2025: COVID-19 Pandemic Impact Updates with Executive and Consultant Guides - ResearchAndMarkets.com Businesswire
09-Apr-2021 Global Calibration Services Market Strategies and Trends Report 2021-2025: Type of Calibration, Industry and Country Including Metropolitan Area Market Sizes - ResearchAndMarkets.com Businesswire
09-Apr-2021 Global Single Cell Genomics Market Forecasts 2021-2025 by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates - ResearchAndMarkets.com Businesswire